Skip to content

Clinical trials

Phase 2 Adenocarcinoma of Lung trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 2 Country / region: Spain Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20123
20151
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
BerGenBio ASA1
Morphotek1
SOLTI Breast Cancer Research Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung7
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms4
Anus Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Ovarian Epithelial1
Carcinoma, Renal Cell1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1
Melanoma1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.